GlassScriptPhysician profile
Daniel Thomas Hoeltgen
NPI 1710010020
$8,352.44
in general payments reported to CMS, 2019-2025
14 companies · $1,266 in 2025
The $1,266 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,256 · 2020: $791 · 2021: $3,357 · 2022: $416 · 2023: $117 · 2024: $1,151 · 2025: $1,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,642 · Food and Beverage: $882 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,642.32 |
| Food and Beverage | $882.49 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,567.09 | 2019-2025 | |
| Covidien LP | $714.28 | 2019-2020 | |
| Novo Nordisk INC | $307.11 | 2019-2022 | |
| Ethicon US, LLC | $163.41 | 2019-2022 | |
| Conmed Corporation | $145.62 | 2022 | |
| Baxter Healthcare | $116.69 | 2023 | Tisseel |
| W. L. Gore & Associates, INC. | $101.83 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $71.61 | 2024-2025 | |
| Medtronic, INC. | $62.27 | 2021 | |
| Sirius Medical Systems | $38.65 | 2024 | Pintuition |
| Braintree Laboratories, INC. | $20.24 | 2025 | Sutab, Suflave |
| Amgen INC. | $15.90 | 2019 | |
| Pfizer INC. | $15.62 | 2021 | |
| Davol INC. | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoeltgen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.